[Trith]

As you read, he said that the doctors are writing the article, and I am eager to read it like you, and I will definitely ask the names of the doctors and the link to the article, I will do whatever help I can, wherever I am in the world. You don't know how happy I am because I can't believe that an article about Biperiden is being written for DP by two Iranian doctors. I must find these two doctors and tell them about my experience and become one of the cases.
I am in touch with you through this site and will share the latest news of these two doctors

Conducting a study, writing the article, submitting it, leaving time for reviewers to read it and give their critical answer (usually a month), answering to reviewers and getting it accepted (or not, which means rewriting or even doing more experiments, and sending back to the reviewers and giving them more time again) can take several months or more than a year. So in the mean time I think it can be interesting to have the name of this doctor just so that we can check his previous works on DP if any. It also helps if we want to put an alert and get the information automatically when he publishes something new.
Also where I live I believe you can't even start the study unless you have submitted your project to a board that checks if the study is ethical or not. After all, they are doing experiments on human beings, and if you are going to give medicines to people that are not approved by the 'FDA' of your country for that specific disease, and then if you are going to advertise about it, this is useful too. This usually takes time too.

 

[nocturnalman]

I don't understand how they think sometimes at the FDA.For example amisulpride is not approved in the USA but almost everywhere in the world and many times they reject an already available drug in liquid form.What is the logic behind this ?

 

[Trith]

I don't understand how they think sometimes at the FDA.For example amisulpride is not approved in the USA but almost everywhere in the world and many times they reject an already available drug in liquid form.What is the logic behind this ?

I didn't know that. Here is what I found:

“I figured the newer medications would come out on top, but the results showed first-generation antipsychotics performed better,” he said. “And the driving force seemed to be a first-generation antipsychotic I had never heard of called sulpride.

Though sulpride was already a generic (and thus unlikely to be approved in the United States), there was a newer analog of sulpride called amisulpride that also showed strong efficacy in several European studies. Grattan was hopeful that this newer compound, which still had patent protection, would find its way to the United States.

In fact, the French company Sanofi, which manufactured amisulpride, submitted a new drug application to the FDA in 1998, but the company later withdrew this application. Though the official company statement did not provide details, LB Co-founder and CEO Zachary Prensky said he believes the impetus was financial. “The patent was expiring in a few years, and the leadership calculated the cost and time required to complete all the required trials would not be profitable,” he said."

" [...] And Marder noted that since the patent on amisulpride expired in 2008, it is unlikely to ever gain approval from the Food and Drug Administration (FDA); there is little financial incentive for companies to sponsor the necessary clinical testing for a generic medicine. " Beautiful...

Amisulpride: What’s Old Can Be New in the United States

Evidence points to amisulpride as perhaps the most effective antipsychotic when weighing all the benefits and risks, but this generic drug is not available in the United States.

psychnews.psychiatryonline.org

So this says it was too late to submit it, but it doesn't say why the US didn't do like other countries and get it approved on time.

But it is authorized as injected, for postoperative nausea:

SOLIAN – New Drug Approvals

Posts about SOLIAN written by DR ANTHONY MELVIN CRASTO Ph.D

newdrugapprovals.org

 

[mehrdadrad]

Conducting a study, writing the article, submitting it, leaving time for reviewers to read it and give their critical answer (usually a month), answering to reviewers and getting it accepted (or not, which means rewriting or even doing more experiments, and sending back to the reviewers and giving them more time again) can take several months or more than a year. So in the mean time I think it can be interesting to have the name of this doctor just so that we can check his previous works on DP if any. It also helps if we want to put an alert and get the information automatically when he publishes something new.
Also where I live I believe you can't even start the study unless you have submitted your project to a board that checks if the study is ethical or not. After all, they are doing experiments on human beings, and if you are going to give medicines to people that are not approved by the 'FDA' of your country for that specific disease, and then if you are going to advertise about it, this is useful too. This usually takes time too.

I think he’s mean was web md I don’t know, I’m not professional likes you but I ask her what is dr name he said is dr masoud namjo , you can write Iranian doctor derealization maybe work they have some articles

 

[mehrdadrad]

Any my top and favorite pills on dp is zolpidem , king on kings 😂

 

[Amir23]

Salam mnk iraniam bavaram nmishe too iranm ksi ba in mskl hast

 

[Amir23]

Lotfan javab bede

 

[mehrdadrad]

Lotfan javab bede

Salam dash Manam bavaram Nemishe inja hasti, telegram ya what’s app Dari ?

 

[mehrdadrad]

Lotfan javab bede

to iran ke kam nistim vali bi kasim dash hichki sar az dard ma dar nemiare

 

[Amir23]

to iran ke kam nistim vali bi kasim dash hichki sar az dard ma dar nemiare

Vay aval matneto khoondam bavaram nashod
Telegram dari?id to bezar

 

[mehrdadrad]

Vay aval matneto khoondam bavaram nashod
Telegram dari?id to bezar

@Mehrdad_Heydari_Rad
Bia dash

 

[Saschasascha]

Anything new?